Literature DB >> 17044051

Prediction of chromosomal aneuploidy from gene expression data.

Libi Hertzberg1, David R Betts, Susana C Raimondi, Beat W Schäfer, Daniel A Notterman, Eytan Domany, Shai Izraeli.   

Abstract

Chromosomal aneuploidy is commonly observed in neoplastic diseases and is an important prognostic marker. Here we examine how gene expression profiles reflect aneuploidy and whether these profiles can be used to detect changes in chromosome copy number. We developed two methods for detecting such changes in the gene expression profile of a single sample. The first method, fold-change analysis, relies on the availability of gene expression data from a large cohort of patients with the same disease. The expression profile of the sample is compared with that of the dataset. The second method, chromosomal relative expression analysis, is more general and requires the expression data from the tested sample only. We found that the relative expression values are stable among different chromosomes and exhibit little variation between different normal tissues. We exploited this novel finding to establish the set of reference values needed to detect changes in the copy number of chromosomes in a single sample on the basis of gene expression levels. We measured the accuracy of the performance of each method by applying them to two independent leukemia datasets. The second method was also applied to two solid tumor datasets. We conclude that chromosomal aneuploidy can be detected and predicted by analysis of gene expression profiles. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17044051     DOI: 10.1002/gcc.20391

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  21 in total

1.  Bayesian method to predict individual SNP genotypes from gene expression data.

Authors:  Eric E Schadt; Sangsoon Woo; Ke Hao
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

Review 2.  The consequences of chromosomal aneuploidy on the transcriptome of cancer cells.

Authors:  Thomas Ried; Yue Hu; Michael J Difilippantonio; B Michael Ghadimi; Marian Grade; Jordi Camps
Journal:  Biochim Biophys Acta       Date:  2012-03-06

3.  Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells.

Authors:  Xin Zhao; Shouguo Gao; Zhijie Wu; Sachiko Kajigaya; Xingmin Feng; Qingguo Liu; Danielle M Townsley; James Cooper; Jinguo Chen; Keyvan Keyvanfar; Maria Del Pilar Fernandez Ibanez; Xujing Wang; Neal S Young
Journal:  Blood       Date:  2017-10-13       Impact factor: 22.113

4.  DYRK1A in Down syndrome: an oncogene or tumor suppressor?

Authors:  Yehudit Birger; Shai Izraeli
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

Review 5.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

6.  An improved method for detecting and delineating genomic regions with altered gene expression in cancer.

Authors:  Björn Nilsson; Mikael Johansson; Anders Heyden; Sven Nelander; Thoas Fioretos
Journal:  Genome Biol       Date:  2008-01-21       Impact factor: 13.583

7.  Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.

Authors:  Yehudit Birger; Liat Goldberg; Timothy M Chlon; Benjamin Goldenson; Inna Muler; Ginette Schiby; Jasmin Jacob-Hirsch; Gideon Rechavi; John D Crispino; Shai Izraeli
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

8.  Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer.

Authors:  Michal Sheffer; Manny D Bacolod; Or Zuk; Sarah F Giardina; Hanna Pincas; Francis Barany; Philip B Paty; William L Gerald; Daniel A Notterman; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

9.  Gene set enrichment analysis using linear models and diagnostics.

Authors:  Assaf P Oron; Zhen Jiang; Robert Gentleman
Journal:  Bioinformatics       Date:  2008-09-11       Impact factor: 6.937

10.  Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.

Authors:  N Gefen; V Binder; M Zaliova; Y Linka; M Morrow; A Novosel; L Edry; L Hertzberg; N Shomron; O Williams; J Trka; A Borkhardt; S Izraeli
Journal:  Leukemia       Date:  2009-11-05       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.